Current plan

Explorer

Upgrade

Payment details required

One or more limits reached

Daily profile views

0 / 3

Monthly profile views

0 / 15

Searches (last 30 days)

0 / 10

Add Entity

Startup Nation Finder

Current plan

Explorer

Pricing plans

Payment details required

Daily profile views

0 / 3

Monthly profile views

0 / 15

Searches (last 30 days)

0 / 10

Watchlist name*

Watchlist must have a valid name.

Description (optional)

0/300

Notifications Settings

Public content (accessible by all Finder users)

Add to List

Select notifications to recieve

Select all

Email Alerts

Receive notifications via email

Daily

Weekly

Monthly

Never

No Notifications are selected

Would you like to select any notifications?

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
#COMPANY_NAME#’s page on Startup Nation Finder

The invitation to claim the profile was originally sent to

Hey #USER_FULLNAME#!

Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
#COMPANY_NAME#’s page on Startup Nation Finder

Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

Name*

Work Email* (please provide your email in the organization)

Position*

Notes

8 Characters, Uppercase letter (A-Z),
Lowercase letter (a-z), Digit (0-9)

Passwords do not match

I agree to receive Informational Emails from Startup Nation Finder as defined in the Privacy Policy and Terms of Use

Already have an account?

Or continue with

Home > Multinationals > Bayer

Claimed by owner • Last Update Oct 8, 2024 • Suggest Edits • Claim Profile

Claimed by owner

Bayer

Pharmaceuticals • Germany

PUBLIC on FWB on Oct, 1954

Bayer

Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz

Dermatomycoses Market Report 2025-2035, Profiles of Prominent Players - Kaken Pharma, Novartis, Glenmark Pharma, Sun Pharma, Teva Pharmaceutical, Bayer, and Galderma

NurExone Announces Corporate Updates

Guidde Raises $50M to Train Humans on AI and AI on Humans

#Investment #Customers

J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales

OpenAI תשיק גרסה ייעודית של ChatGPT למענה על שאלות רפואיות. המחיר: ויתור על הפרטיות ● חוקרים מאוניברסיטת סטנפורד מראים שלילה אחד של שינה יכול לנבא עשרות מחלות ברמות דיוק של 80% ומעלה ● באייר מקימה בישראל מעבדה שתדמה מתקפות סייבר על מפעלי תרופות, וחברות ישראליות מציגות פריצות דרך – מטיפול ואבחון סרטן ועד "אינקובטור חיבוק" לפגים ● השבוע בביומד

#Investment #Product Stage

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting

#Product Stage #Partners

Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro

#Product Stage #Partners

JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit

Stocks to watch next week: BP, Diageo, Disney, Uber and WPP

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA

#Product Stage

Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy

#Partners

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with...

#Product Stage #Partners

Bayer, AgPlenus Team Up to Develop a New Sustainable Weed Control Solution Using AI Technology

#Partners #Investment

Pharma giant Bayer to set up cybersecurity center in Israel

#Partners

https://www.jpost.com/health-science/bayer-to-test-new-drugs-on-3d-printed-heart-tissue-at-tel-aviv-university-633162

#Partners #Customers

Pharma giant Bayer scouts Israeli startup scene in search of competitive edge

#Partners #Investment

Bayer leads $40m investment in Israeli biotech co Ukko

#Investment

https://www.israelhayom.com/2020/07/28/bayers-leaps-to-invest-in-israeli-biotech-incubator-futurx/

Netafim, BGU, Bayer To Collaborate On Drip Irrigation Systems

#Partners

Bayer AG is a global life science company with four main segments: pharmaceuticals, consumer health, crop science, and animal health.

In 2018, Bayer acquired Monsanto, including all of its operations in Israel and former subsidiaries. Bayer now operates in Israel through its fully owned subsidiary, Bayer Israel, which manages the pharmaceutical, consumer health, and crop science divisions. Additionally, Bayer runs an R&D site focused on vegetable seed breeding as part of its crop science division.

Since 2022, Bayer has also been operating a Digital Hub in Israel, integrated into its global R&D network, which focuses on cybersecurity solutions. Furthermore, Bayer has partnered with the Israeli Innovation Authority to lead an International Climate Tech Program.

Bayer is actively scouting Israeli innovations in pharma, agriculture, and digital health technologies, and conducts numerous clinical trials in Israel.

Founded

5/1863

In Israel Since

6/2008

Employees Worldwide

50,000+

Employees In Israel

51-200

Market Cap

$44.51B

Market Cap Update

5/2026

Country

Germany

News

(21)

Dermal Mycosis Market Research Report 2025-2026 & 2035, Competitive Analysis of Bayer, Kenvue, Karo Healthcare, Novartis, Glenmark Pharmaceuticals, Sun Pharma, Teva, and Sandoz

Dermatomycoses Market Report 2025-2035, Profiles of Prominent Players - Kaken Pharma, Novartis, Glenmark Pharma, Sun Pharma, Teva Pharmaceutical, Bayer, and Galderma

NurExone Announces Corporate Updates

Guidde Raises $50M to Train Humans on AI and AI on Humans

#Investment #Customers

J&J Stock Down Despite Q4 Earnings Beat, Oncology Drugs Drive Sales

#Investment #Product Stage

Galmed Announces Acceptance of a Late-Breaking Abstract to be Presented at HEP-DART 2025 Meeting

#Product Stage #Partners

Galmed Announces Top-line Results in Oncology MoA Studies: A 3-drug combination of Aramchol, Stivarga® and Metformin Significantly Enhanced GI Tumor Cells, Killing In-vivo and In-vitro

#Product Stage #Partners

JNJ Beats on Q3 Earnings, Ups Sales View, to Spin-off Orthopaedics Unit

Stocks to watch next week: BP, Diageo, Disney, Uber and WPP

Multiple Sclerosis Clinical Trials Market Landscape Report 2025 Featuring Biogen, Novartis, Sanofi, Merck, Teva, Bayer, Roche, Bristol-Myers Squibb, Laboratory Corp of America, IQVIA

#Product Stage

Agricultural Biotechnology Market Outlook Report to 2030, with Profiles of Bayer, Corteva, Syngenta, BASF, FMC, Bioceres Crop Solutions, Evogene, Marrone Bio Innovations, Calyxt & Arcadia Biosciences

Teva Partners With Fosun to Develop TEV-56278 Immuno-Cancer Therapy

#Partners

The 80-patient placebo-controlled randomized Phase 2 study will evaluate the efficacy of opaganib in combination with Bayer's darolutamide in men with...

#Product Stage #Partners

Bayer, AgPlenus Team Up to Develop a New Sustainable Weed Control Solution Using AI Technology

#Partners #Investment

Pharma giant Bayer to set up cybersecurity center in Israel

#Partners

https://www.jpost.com/health-science/bayer-to-test-new-drugs-on-3d-printed-heart-tissue-at-tel-aviv-university-633162

#Partners #Customers

Pharma giant Bayer scouts Israeli startup scene in search of competitive edge

#Partners #Investment

Bayer leads $40m investment in Israeli biotech co Ukko

#Investment

https://www.israelhayom.com/2020/07/28/bayers-leaps-to-invest-in-israeli-biotech-incubator-futurx/